Hims & Hers Health, Inc. (NYSE:HIMS) Given Average Rating of “Hold” by Analysts

Hims & Hers Health, Inc. (NYSE:HIMS) has received a consensus recommendation of “Hold” from the fifteen research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $37.31.

HIMS has been the topic of several research analyst reports. Leerink Partners lifted their price objective on shares of Hims & Hers Health from $24.00 to $40.00 and gave the stock a “market perform” rating in a research report on Tuesday, February 25th. Morgan Stanley cut Hims & Hers Health from an “overweight” rating to an “equal weight” rating and raised their target price for the stock from $42.00 to $60.00 in a research report on Tuesday, February 18th. Canaccord Genuity Group upped their price target on Hims & Hers Health from $38.00 to $68.00 and gave the company a “buy” rating in a research report on Wednesday, February 19th. Piper Sandler raised their price objective on Hims & Hers Health from $24.00 to $35.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 25th. Finally, Citigroup reaffirmed a “sell” rating and set a $27.00 target price on shares of Hims & Hers Health in a research note on Thursday, March 6th.

Hims & Hers Health Stock Up 5.0 %

HIMS opened at $31.04 on Wednesday. The firm has a market cap of $6.90 billion, a PE ratio of 70.54 and a beta of 1.37. The business has a fifty day simple moving average of $39.94 and a 200-day simple moving average of $29.78. Hims & Hers Health has a fifty-two week low of $11.20 and a fifty-two week high of $72.98.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings data on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.02. The firm had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. On average, equities research analysts anticipate that Hims & Hers Health will post 0.29 EPS for the current fiscal year.

Insider Activity

In other news, insider Soleil Boughton sold 3,236 shares of the firm’s stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $27.77, for a total value of $89,863.72. Following the sale, the insider now directly owns 170,285 shares of the company’s stock, valued at approximately $4,728,814.45. This trade represents a 1.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Andrew Dudum sold 36,460 shares of the stock in a transaction that occurred on Thursday, January 16th. The shares were sold at an average price of $27.09, for a total value of $987,701.40. Following the sale, the chief executive officer now owns 27,918 shares of the company’s stock, valued at approximately $756,298.62. The trade was a 56.63 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,064,954 shares of company stock valued at $37,984,259. Insiders own 17.71% of the company’s stock.

Hedge Funds Weigh In On Hims & Hers Health

Several large investors have recently bought and sold shares of the stock. Main Management ETF Advisors LLC acquired a new position in shares of Hims & Hers Health during the third quarter valued at about $672,000. Blueshift Asset Management LLC increased its stake in Hims & Hers Health by 834.8% during the third quarter. Blueshift Asset Management LLC now owns 245,013 shares of the company’s stock valued at $4,513,000 after acquiring an additional 218,804 shares during the period. Means Investment CO. Inc. raised its holdings in Hims & Hers Health by 23.5% in the 4th quarter. Means Investment CO. Inc. now owns 50,040 shares of the company’s stock valued at $1,210,000 after acquiring an additional 9,508 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Hims & Hers Health by 102.0% in the 3rd quarter. Principal Financial Group Inc. now owns 290,414 shares of the company’s stock worth $5,349,000 after acquiring an additional 146,621 shares during the period. Finally, State of Alaska Department of Revenue acquired a new stake in shares of Hims & Hers Health during the 4th quarter worth approximately $2,628,000. 63.52% of the stock is currently owned by institutional investors and hedge funds.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.